Symptom assessment in early psychosis: The use of well-established rating scales in clinical high-risk and recent-onset populations

Psychiatry Research

Volumn 220, Issue 3, 2014, Pages 1077-1083

  Fulford, Daniel ^a,b   Pearson, Rahel ^a   Stuart, Barbara K ^a   Fisher, Melissa ^a,c   Mathalon, Daniel H ^a,c   Vinogradov, Sophia ^a,c   Loewy, Rachel L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PALO ALTO MEDICAL FOUNDATION RESEARCH INSTITUTE   (United States)

^c San Francisco VA Healthcare System   (United States)

Author keywords

Assessment; BPRS; Early psychosis; PANSS; SANS SAPS; SOPS; Symptoms

Indexed keywords

ADULT; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; DISEASE SEVERITY; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; NEGATIVE SYNDROME; ONSET AGE; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRODROMAL SYMPTOM; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; RISK ASSESSMENT; SCALE FOR THE ASSESSMENT OF NEGATIVE SYMPTOM; SCALE FOR THE ASSESSMENT OF POSITIVE SYMPTOM; SCALE OF PRODROMAL SYMPTOM; SCORING SYSTEM; SELF REPORT; STRUCTURED INTERVIEW; SYMPTOMATOLOGY; ADOLESCENT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMETRY; PSYCHOTIC DISORDERS; RISK; SCHIZOPHRENIA; STATISTICS AND NUMERICAL DATA; SYMPTOM ASSESSMENT; YOUNG ADULT;

ADOLESCENT; BRIEF PSYCHIATRIC RATING SCALE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PRODROMAL SYMPTOMS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOTIC DISORDERS; RISK; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SYMPTOM ASSESSMENT; YOUNG ADULT;

EID: 84919838374     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.07.047     Document Type: Article

References (50)

1. Diagnostic and Statistical Manual of Mental Disorders. DSM-IV-TR 2000, American Psychiatric Association, American Psychiatric Publishing Inc, Arlington.
2. Andreasen N.C. Negative symptoms in schizophrenia definition and reliability. Archives of General Psychiatry 1982, 39:784-788.
3. Andreasen N.C. Scale for the Assessment of Positive Symptoms 1984, University of Iowa press, Iowa City.
4. Andreasen N.C., Arndt S., Alliger R., Miller D., Flaum M. Symptoms of schizophrenia methods, meaning and mechanism. Archives of General Psychiatry 1995, 52:341-351.
5. Arndt S., Turvey C., Andreasen N.C. Correlating and predicting psychiatric symptom ratings: Spearman r versus Kendall[U+05F3]s tau correlation. Journal of Psychiatric Research 1999, 33:97-104.
6. Auther A.M., Smith C.W., Cornblatt B.A. Global Functioning: Social Scale (GF: Social) 2006, Zucker-Hillside Hospital, Glen Oaks.
7. Barch D.M., Carter C.S., MacDonald A.W., Braver T.S., Cohen J.D. Context-processing deficits in schizophrenia: diagnostic specificity, 4-week course, and relationship to clinical symptoms. Journal of Abnormal Psychology 2003, 112:132-143.
8. Barnett V., Lewis T. Outliers in Statistical Data 1978, Wiley, New York.
9. Bell M., Milstein R., Beam-Goulet J., Lysaker P., Cicchetti D. The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability, and predictive validity. Journal of Nervous and Mental Disease 1992, 180:723-728.
10. Brekke J.S., DeBonis J.A., Graham J.W. A latent structure of the positive and negative symptoms in schizophrenia. Comprehensive Psychiatry 1994, 35:252-259.
11. Corcoran C.M., Kimhy D., Parrilla-Escobar M.A., Cressman V.L., Stanford A.D., Thompson J., Ben David S., Crumbley A., Schobel S., Moore H., Malaspina D. The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychological Medicine 2011, 41:251-261.
12. Cornblatt B.A., Auther A.M., Niendam T., Smith C.W., Zinberg J., Bearden C.E., Cannon T.D. Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophrenia Bulletin 2007, 33:688-702.
13. Emsley R., Rabinowitz J., Torreman M. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophrenia Research 2003, 61:47-57.
14. Fenton W.S., McGlashan T.H. Testing systems for assessment of negative symptoms in schizophrenia. Archives of General Psychiatry 1992, 49:179-184.
15. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) 2002, Biometrics Research, New York State Psychiatric Institute, New York.
16. Fisher, M., Loewy, R., Carter, C., Lee, A., Ragland, J.D., Niendam, T., Schlosser, D., Pham, L., Miskovich, T., Vinogradov, S., 2014. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophrenia Bulletin, (First published online: January 20, 2014). http://dx.doi.org/10.1093/schbul/sbt232.
17. Fulford D., Niendam T.A., Floyd E.G., Carter C.S., Mathalon D.H., Vinogradov S., Stuart B.K., Loewy R.L. Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms. Schizophrenia Research 2013, 147:125-131.
18. Fusar-Poli P., Bonoldi I., Yung A.R., Borgwardt S., Kempton M.J., Valmaggia L., McGuire P. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. JAMA Psychiatry 2012, 69:220-229.
19. Gur R.E., Mozley P.D., Resnick S.M., Levick S., Erwin R., Saykin A.J., Gur R.C. Relations among clinical scales in schizophrenia. American Journal of Psychiatry 1991, 148:472-478.
20. Guy W. ECDEU Assessment Manual for Psychopharmacology 1976, U.S. Department of Health, Education, and Welfare, Rockville, MD.
21. Haddock G., McCarron J., Tarrier N., Faragher E.B. Scales to measure dimensions of hallucinations and delusions: the Psychotic Symptom Rating Scales (PSYRATS). Psychological Medicine 1999, 29:879-889.
22. Hawkins K.A., McGlashan T.H., Quinlan D., Miller T.J., Perkins D.O., Zipursky R.B., Addington J., Woods S.W. Factorial structure of the Scale of Prodromal Symptoms. Schizophrenia Research 2004, 68:339-347.
23. Jerrell J.M., Hrisko S. A comparison of the PANSS Pentagonal and Van Der Gaag 5-factor models for assessing change over time. Psychiatry Research 2013, 15:134-139.
24. John J.P., Khanna S., Thennarasu K., Reddy S. Exploration of dimensions of psychopathology in neuroleptic-naïve patients with recent-onset schizophrenia/schizophreniform disorder. Psychiatry Research 2003, 121:11-20.
25. Kaufman, J., Birmaher, B., Brent, D., Rao, U., Ryan, N., 1996. K-SADS-PL. Retrieved from http://www.wpic.pitt.edu/ksads/default.htm.
26. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
27. Kendall M.G., Stuart A. The Advanced Theory of Statistics 1958, Hafner, New York.
28. Klaassen R.M.C., Velthorst E., Nieman D.H., de Haan L., Becker H.E., Dingemans P.M., van de Fliert J.R., van der Gaag M., Linszen D.H. Factor analysis of the scale of prodromal symptoms: differentiating between negative symptoms and depression symptoms. Psychopathology 2011, 44:379-385.
29. Kopelowicz A., Ventura J., Liberman R.P., Mintz J. Consistency of Brief Psychiatric Rating Scale factor structure across a broad spectrum of schizophrenia patients. Psychopathology 2008, 41:77-84.
30. Liddle P.F. The symptoms of chronic schizophrenia: a re-examination of the positive-negative dichotomy. British Journal of Psychiatry 1987, 151:145-151.
31. Liddle P.F., Ngan E.T.C., Duffield G., Kho K., Warren A.J. Signs and Symptoms of Psychotic Illness (SSPI): a rating scale. The British Journal of Psychiatry 2002, 180:45-50.
32. Lyne J., Kinsella A., O'Donoghue B. Can we combine symptom rating scales for collaborative research projects?. Journal of Psychiatric Research 2012, 46:233-238.
33. McGorry P.D., Bell R.C., Dudgeon P.L., Jackson H.J. The Dimensional structure of first episode psychosis: an exploratory factor analysis. Psychological Medicine 1998, 28:935-947.
34. Miller T.J., McGlashan T.H, Rosen J.L., Cadenhead K., Ventura J., McFarlane W., Perkins D.O., Pearlson G.D., Woods S.W. Prodromal assessment with the structured interview for prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophrenia Bulletin 2003, 29:703-715.
35. Niendam T.A., Bearden C.E., Johnson J.K., Cannon T.D. Global Functioning: Role Scale (GF: Role) 2006, University of California, Los Angeles, Los Angeles.
36. Niendam T.A., Bearden C.E., Zinberg J., Johnson J.K., O'Brien M., Cannon T.D. The course of neurocognition and social functioning in individuals at ultra high risk for psychosis. Schizophrenia Bulletin 2007, 33:772-781.
37. Norman R.M.G., Malla A.K., Cortese L., Diaz F. A study of the interrelationship between and comparative interrater reliability of the SAPS, SANS and PANSS. Schizophrenia Research 1996, 19:73-85.
38. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychological Reports 1962, 10:799-812.
39. Peralta V., Cuesta M.J. How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophrenia Research 2001, 49:269-285.
40. Peralta V., Cuesta M.J., De Leon J. Positive and negative symptoms/syndromes in schizophrenia: reliability and validity of different diagnostic systems. Psychological Medicine 1995, 25:43-50.
41. Roncone R., Ventura J., Impallomeni M., Falloon I.R.H., Morosini P.L., Chiavalle E., Casacchia M. Reliability of an Italian standardized and expanded Brief Psychiatric Rating Scale (BPRS 4.0) in raters with high vs low clinical experience. Acta Psychiatrica Scandinavica 1999, 100:229-236.
42. Shim G.S., Kang D.H., Choi J.S., Jung M.H., Kwon S.J., Jang G.E., Kwon J.S. Prospective outcome of early intervention for individuals at ultra-high-risk for psychosis. Early Intervention in Psychiatry 2008, 2:277.
43. Shrout P.E., Fleiss J.L. Intraclass correlations: uses in assessing rater reliability. Psychological Bulletin 1979, 86:420-428.
44. Singh M.M., Kay S.R. A comparative study of haloperidol and chlorpromazine in terms of clinical effect and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics. Psychopharmacologica 1975, 43:103-113.
45. Thiemann S., Csernansky J.G., Berger P.A. Rating scales in research: the case of negative symptoms. Psychiatry Research 1987, 20:47-55.
46. van der Gaag M., Hoffman T., Remijnsen M., Hijman R., de Haan L., van Meijel B., van Harter P.N., Valmaggia L., de Hert M., Cuijpers A., Wiersma D. The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model. Schizophrenia Research 2006, 85:280-287.
47. Ventura J., Green M.F., Shaner A., Liberman R.P. Training and quality assurance with the Brief Psychiatric Rating Scale: "The drift busters". Psychiatric Research 1993, 3:221-244.
48. Welham J., Stedman T., Clair A. Choosing negative symptom instruments: issues of representation and redundancy. Psychiatry Research 1999, 87:47-56.
49. Yung A.R., Yuen H.P., McGorry P.D., Phillips L.J., Kelly D., Dell'Ollio M., Francey S.M., Cosgrave E.M., Killackey E., Stanford C., Godfrey K., Buckby J. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Australian and New Zealand Journal of Psychiatry 2005, 39:964-971.
50. Yung A.R., Yuen H.P., Berger G., Francey S., Hung T., Nelson B., Phillips L., McGorry P. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?. Schizophrenia Bulletin 2007, 33:673-681.